Search Results 21-30 of 17328 for egfr

  1. Osimertinib (oral route) - Side effects & dosage - Mayo Clinic

    ... EGFR tyrosine kinase inhibitor (TKI) treatment, which did not work. Your doctor will perform a test to check for the EGFR gene before you use this medicine.

  2. Pulmonary Medicine - Clinical trials

    Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...

  3. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations ... (EGFR) mutations. Erlotinib may ...

  4. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) - Mayo Clinic

    Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR ...

  5. Study Of ORIC-114 In Patients With Advanced Solid Tumors Harboring An EGFR Or HER2 Alteration - Mayo Clinic

    Study Of ORIC-114 In Patients With Advanced Solid Tumors Harboring An EGFR Or HER2 Alteration · Overview · Participation eligibility · Participating Mayo Clinic ...

  6. Mayo Clinic opens new doors in cancer treatment innovation

    These include human epidermal growth factor receptor 2 (HER2), epidermal growth factor receptor (EGFR), and mesenchymal-epithelial transition factor (MET).

  7. A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label - Mayo Clinic

    A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated ...

  8. Cancer-Causing Gene Alone Doesn't Trigger Pancreatic Cancer, Mayo-led Study Finds

    ... EGFR.A third genetic participant known as Trp53 makes pancreatic tumors very difficult to treat, the study showed. The scientists also found that EGFR was ...

  9. Amivantamab and hyaluronidase-lpuj (subcutaneous route) - Side effects & uses - Mayo Clinic

    ... (EGFR) gene (exon 19 deletions or exon 21 L858R substitution mutations). This medicine is also used in combination with carboplatin and pemetrexed to treat ...

  10. Hemodialysis - Mayo Clinic

    Your doctor uses your estimated glomerular filtration rate (eGFR) to measure your level of kidney function. Your eGFR is calculated using your blood ...